Literature DB >> 4181003

Immunologic aspects of experimental Mycoplasma pneumoniae infection.

G W Fernald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4181003     DOI: 10.1093/infdis/119.3.255

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  13 in total

1.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

2.  Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters.

Authors:  J V Jemski; C M Hetsko; C M Helms; M B Grizzard; J S Walker; R M Chanock
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  In vitro response of human lymphocytes to Mycoplasma pneumoniae.

Authors:  G W Fernald
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

4.  Mycoplasma pneumoniae vaccine: antigenicity of buffered antigens in volunteers.

Authors:  R C Brown; J O Hendley; J M Gwaltney
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

5.  Isolation of mycoplasmas from lungs by a perfusion technique.

Authors:  D Taylor-Robinson; F W Denny; G W Thompson; A C Allison; P A Mårdh
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

6.  Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains.

Authors:  R P Lipman; W A Clyde; F W Denny
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

7.  Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Authors:  Ana María Ríos; Asunción Mejías; Susana Chávez-Bueno; Mónica Fonseca-Aten; Kathy Katz; Jeanine Hatfield; Ana María Gómez; Hasan S Jafri; George H McCracken; Octavio Ramilo; Robert Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.

Authors:  M F Barile; D K Chandler; H Yoshida; M W Grabowski; S Razin
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Immunopathology of experimental Mycoplasma pneumoniae disease.

Authors:  W A Clyde
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

10.  Exfoliation of respiratory epithelium in hamster tracheal organ cultures infected with Mycoplasma pneumoniae.

Authors:  G F Murphy; A R Brody; J E Craighead
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.